Aptamer Sciences Inc
Develops aptamer-based therapeutics and diagnostics for oncology and solid tumors.
291650 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 분당구 판교로228번길 15 3동 301호(삼평동, 판교세븐벤처밸리1), 성남시
- Website:
- https://aptsci.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Aptamer Sciences Inc. is a clinical-stage biopharmaceutical company specializing in the development of innovative aptamer-based technologies for therapeutics and diagnostics. The company leverages its proprietary integrated platforms to address unmet medical needs, primarily in oncology. Its therapeutic pipeline is centered on the ApDC™ (Aptamer-Drug Conjugate) platform, with lead candidate AST-201 advancing to clinical trials for treating GPC3-positive solid tumors like liver cancer. In the diagnostics segment, the company has developed and commercialized the AptoDetect™ platform, which includes AptoDetect™-Lung, an aptamer-based diagnostic kit for assessing lung cancer risk. Aptamer Sciences focuses on advancing its pipeline and forming strategic partnerships to commercialize its novel aptamer technologies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-15 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 84.4 KB | ||
| 2025-09-15 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 104.9 KB | ||
| 2025-09-09 00:00 |
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
|
Korean | 4.2 KB | ||
| 2025-09-09 00:00 |
Share Issue/Capital Change
주요사항보고서(유상증자결정)
|
Korean | 39.4 KB | ||
| 2025-09-09 00:00 |
Share Issue/Capital Change
주요사항보고서(전환사채권발행결정)
|
Korean | 40.2 KB | ||
| 2025-09-09 00:00 |
Share Issue/Capital Change
주요사항보고서(유상증자결정)
|
Korean | 51.0 KB | ||
| 2025-09-09 00:00 |
Pre-Annual General Meeting Information
주주총회소집결의 (임시주주총회)
|
Korean | 5.9 KB | ||
| 2025-09-09 00:00 |
Capital/Financing Update
[기재정정]주요사항보고서(전환사채권발행결정)
|
Korean | 77.9 KB | ||
| 2025-09-08 00:00 |
M&A Activity
경영권변경등에관한계약체결
|
Korean | 15.1 KB | ||
| 2025-08-20 00:00 |
Regulatory News Service
단일판매ㆍ공급계약체결
|
Korean | 10.3 KB | ||
| 2025-08-14 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 891.5 KB | ||
| 2025-07-03 00:00 |
Regulatory News Service
풍문또는보도에대한해명
|
Korean | 4.4 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 745.9 KB | ||
| 2025-04-07 00:00 |
Capital/Financing Update
전환사채(해외전환사채포함)발행후만기전사채취득
|
Korean | 10.2 KB | ||
| 2025-03-27 00:00 |
Post-Annual General Meeting Information
정기주주총회결과
|
Korean | 26.5 KB |
Automate Your Workflow. Get a real-time feed of all Aptamer Sciences Inc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Aptamer Sciences Inc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
